Cargando…

A Comparison of Fosaprepitant and Ondansetron for Preventing Postoperative Nausea and Vomiting in Moderate to High Risk Patients: A Retrospective Database Analysis

Postoperative nausea and vomiting (PONV) occur in 30–50% of patients undergoing general anesthesia and in 70–80% of high PONV risk patients. In this study, we investigated the efficacy of fosaprepitant, a neurokinin-1 (NK1) receptor antagonist, compared to ondansetron, a selective 5-hydroxytryptamin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murakami, Chiaki, Kakuta, Nami, Kume, Katsuyoshi, Sakai, Yoko, Kasai, Asuka, Oyama, Takuro, Tanaka, Katsuya, Tsutsumi, Yasuo M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749222/ https://www.ncbi.nlm.nih.gov/pubmed/29410964 http://dx.doi.org/10.1155/2017/5703528

Ejemplares similares

The Effects of Intravenous Fosaprepitant and Ondansetron for the Prevention of Postoperative Nausea and Vomiting in Neurosurgery Patients: A Prospective, Randomized, Double-Blinded Study
por: Tsutsumi, Yasuo M., et al.
Publicado: (2014)

Plasma substance P concentrations in patients undergoing general anesthesia: an objective marker associated with postoperative nausea and vomiting
por: Kadota, Takako, et al.
Publicado: (2016)

Prevention of chemotherapy-induced nausea and vomiting: focus on fosaprepitant
por: Olver, Ian N
Publicado: (2008)

Neurokinin-1 receptor antagonists for postoperative nausea and vomiting: a systematic review and meta-analysis
por: Murakami, Chiaki, et al.
Publicado: (2020)

Fosaprepitant and aprepitant: an update of the evidence for their place in the prevention of chemotherapy-induced nausea and vomiting
por: Langford, Patrick, et al.
Publicado: (2010)

Fosaprepitant dimeglumine for the management of chemotherapy-induced nausea and vomiting: patient selection and perspectives
por: Candelario, Nellowe, et al.
Publicado: (2016)

Effects of oral carbohydrate with amino acid solution on the metabolic status of patients in the preoperative period: a randomized, prospective clinical trial
por: Tsutsumi, Rie, et al.
Publicado: (2016)

Ondansetron: Lack of efficacy in nausea and vomiting: case report
Publicado: (2021)

Ondansetron-droperidol combination vs. ondansetron or droperidol monotherapy in the prevention of postoperative nausea and vomiting
por: Matsota, Paraskevi, et al.
Publicado: (2015)

The Efficacy of Programmed Intermittent Epidural Bolus for Postoperative Analgesia after Open Gynecological Surgery: A Randomized Double-Blinded Study
por: Satomi, Shiho, et al.
Publicado: (2018)

The Effect of Ondansetron and Dexamethasone on Nausea and Vomiting under Spinal Anesthesia
por: Kalani, Navid, et al.
Publicado: (2017)

General anesthesia of a Japanese infant with Barber-Say syndrome: a case report
por: Hamaguchi, Eisuke, et al.
Publicado: (2016)

Safety, efficacy, and patient acceptability of single-dose fosaprepitant regimen for the prevention of chemotherapy-induced nausea and vomiting
por: Celio, Luigi, et al.
Publicado: (2013)

Remimazolam’s Effects on Postoperative Nausea and Vomiting Are Similar to Those of Propofol after Laparoscopic Gynecological Surgery: A Randomized Controlled Trial
por: Matsumoto, Ayumu, et al.
Publicado: (2023)

The efficacy of combination of ondansetron and aprepitant on preventing the radiotherapy-induced nausea and vomiting
por: Emami, Hamid, et al.
Publicado: (2015)

Effects of palonosetron and ondansetron on preventing nausea and vomiting after laparoscopic surgery
por: Liu, Qili, et al.
Publicado: (2017)

Ramosetron versus ondansetron for postoperative nausea and vomiting in strabismus surgery patients
por: Joo, Jin, et al.
Publicado: (2016)

Pharmacokinetics of Dexamethasone when Administered with Fosaprepitant for Chemotherapy-Induced Nausea and Vomiting and Differences in Dose-Dependent Antiemetic Effects
por: Shimamoto, Fukutaro, et al.
Publicado: (2021)

The efficacy of ginger added to ondansetron for preventing postoperative nausea and vomiting in ambulatory surgery
por: Mandal, Pragnadyuti, et al.
Publicado: (2014)

A Comparison of Preoperative Ondansetron and Dexamethasone in the Prevention of Post-Tympanoplasty Nausea and Vomiting
por: Eidi, Mahmoud, et al.
Publicado: (2012)

A comparison between cetirizine and ondansetron in preventing postoperative nausea and vomiting in adults
por: Lahsaei, Seyed M., et al.
Publicado: (2012)

Should ondansetron be used as a routine prophylaxis agent for postoperative nausea and vomiting?
por: Kendall, Mark C., et al.
Publicado: (2018)

Comparison of Ondansetron and Granisetron Effects for Prevention of Nausea and Vomiting Following Strabismus Surgery
por: Salajegheh, Shirin, et al.
Publicado: (2019)

Acupressure Versus Ondansetron Usage for Postoperative Nausea and Vomiting After Gynecologic Surgeries
por: Ongel, Elif, et al.
Publicado: (2023)

The Effectiveness of Ondansetron and Dexamethasone in Preventing Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy
por: Qasemi, Farzad, et al.
Publicado: (2023)

Cost-EffectivenessAnalysis of Ondansetron and Prochlorperazine for the Prevention of Postoperative Nausea andVomiting
por: Chang, Peter
Publicado: (2005)

Prolonged usage of fosaprepitant for prevention of delayed chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly emetogenic chemotherapy
por: Gao, Ai, et al.
Publicado: (2023)

The effect of 1% glucose loading on metabolism in the elderly patients during remifentanil-induced anesthesia: a randomized controlled trial
por: Fukuta, Kohei, et al.
Publicado: (2020)

Comparison of ondansetron and combination of ondansetron and dexamethasone as a prophylaxis for postoperative nausea and vomiting in adults undergoing elective laparoscopic surgery
por: Bhattarai, Basant, et al.
Publicado: (2011)

Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: results of a randomized, double-blind phase III trial(†)
por: Weinstein, C., et al.
Publicado: (2016)

Comparison between 5-day aprepitant and single-dose fosaprepitant meglumine for preventing nausea and vomiting induced by cisplatin-based chemotherapy
por: Ando, Yosuke, et al.
Publicado: (2015)

Economic Value of Fosaprepitant-Containing Regimen in the Prevention of Chemotherapy-Induced Nausea and Vomiting in China: Cost-Effectiveness and Budget Impact Analysis
por: Xu, Xinglu, et al.
Publicado: (2022)

Palonosetron, Ondansetron, and Granisetron for antiemetic prophylaxis of postoperative nausea and vomiting - A comparative evaluation
por: Gupta, Kumkum, et al.
Publicado: (2014)

Comparison of ramosetron with ondansetron for the prevention of post-operative nausea and vomiting in high-risk patients
por: Agarkar, Sandip, et al.
Publicado: (2015)

Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE
por: Hata, Akito, et al.
Publicado: (2022)

Fosaprepitant Weekly vs Every 3 Weeks for the Prevention of Concurrent Chemoradiotherapy–Induced Nausea and Vomiting: A Pilot Randomized Clinical Trial
por: Yang, Qi, et al.
Publicado: (2023)

Comparison of Azasetron and Ondansetron for Preventing Postoperative Nausea and Vomiting in Patients Undergoing Gynecological Laparoscopic Surgery
por: Yun, Mi Ja, et al.
Publicado: (2010)

Olanzapine with ondansetron and dexamethasone for the prevention of cisplatin-based chemotherapy-induced nausea and vomiting in lung cancer
por: Wang, Wenxian, et al.
Publicado: (2018)

Comparison of ondansetron, tropisetron, and palonosetron for the prevention of postoperative nausea and vomiting after middle ear surgery
por: Aydin, Ahmet, et al.
Publicado: (2019)

Investigation of Ondansetron, Haloperidol, and Dexmedetomidine Efficacy for Prevention of Postoperative Nausea and Vomiting In Patients with Abdominal Hysterectomy
por: Kamali, Alireza, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b0kd3mn0v3ugc0q151mr2f215b